Desk› Healthcare› Syncom Formulations India Ltd

Syncom Formulations India Ltd

BSE 524470 SYNCOMF INE312C01025

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 61 trading days

13 filings · 5 material · busiest 2026-08-11

What it files

General3 Dividend2 Newspaper Publication1 Board Outcome1 Results1 Change in Management1 Other Update1 Board Meeting1

Filings

13 in the window

13 August 2026

General

Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015('Listing Regulations'): Press Release

PURSUANT TO REG 30 SEBI, LODR, WE HEREBY SUBMIT THE PRESS RELEASE ISSUED BY THE COMPANY

Company Update / General View filing →
12 August 2026

Newspaper Publication

Newspaper Publication

Submission of Press Clipping Related to extract of Un-Audited Standalone and Consolidated Financial Result for the Quarter ended on 30th June, 2026.

Company Update / Newspaper Publication View filing →
11 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of The 2/2026-27 Meeting Of The Board Of Directors Of The Company.

Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.

Board Meeting / Outcome of Board Meeting View filing →
11 August 2026

Dividend

Corporate Action-Board approves Dividend

We are pleased to inform you that, pursuant to the provision of Regulation 42 of SEBI (LODR) Regulations, 2015 and Section 91 of the Companies Act, 2013 the "Record Date" has been fixed ....

Corp. Action / Dividend View filing →
11 August 2026

Results

Regulation 33(3) Of SEBI (LODR) Regulations, 2015- Submission Of The Un-Audited Standalone And Consolidated Financial Results Along With Limited Review Report Thereon For The Quarter Ended 30Th June, 2026.

Pursuant to Regulation 33(3) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report thereon ....

Result / Financial Results View filing →
11 August 2026

General

Disclosure Pursuant To Regulation 30 Read With Schedule III Of The SEBI (LODR) Regulations, 2015.

Appointment of Cost Auditor and Internal Auditor for the FY 2026-27.

Company Update / General View filing →
11 August 2026

General

Corporate Announcement/Information Pursuant To Regulation 44 Of The SEBI (LODR) Regulations, 2015

Corporate Announcement/Information pursuant to Regulation 44 of the SEBI (LODR) Regulation, 2015 regarding providing Remote E-Voting facilities for the 38th Annual General Meeting to be ....

Company Update / General View filing →
11 August 2026

Change in Management

Change in Management

Disclosure under Regulation 30(2) read with Clause 7 of Para A of Schedule /// of the SEBI (LODR) Regulation, 2015: Change in directors, KMP and Senior Management.

Company Update / Change in Management View filing →
10 August 2026

Other Update

Resignation of Managing Director

Revised Intimation for resignation of Mr. Vijay Shankarlal Bankda Managing Director Under Regulation 30 of SEBI (LODR) Regulations, 2015.

Company Update / Resignation of Managing Director View filing →
6 August 2026

Board Meeting

Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations, 2015 Read With SEBI (PIT) Regulations, 2015 Regarding Intimation Of Holding The 2/2026-27 Board Meeting Scheduled To Be Held On Tuesday, 11Th Day Of August, 2026.

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve we are pleased to ....

Board Meeting / Board Meeting View filing →
6 August 2026

Dividend

Corporate Action-Board to consider Dividend

Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015, we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday ....

Corp. Action / Dividend View filing →
10 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate for compliance of regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 30th June, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
25 June 2026

Trading Window

Closure of Trading Window

Notice for Trading window Closure for the financials of the quarter ended 30.06.2026

Insider Trading / SAST / Closure of Trading Window View filing →